Lipomas are commonly reported in the extremities and trunk, but orbital lipoma is rare.\[[@ref1]\] Herein, we present an unusual case of a corneal lipoma.

Case Report {#sec1-2}
===========

A 24-year-old male presented with complaints of a painless yellowish lesion over the surface of his right eye that had steadily grown over a year. Slit lamp examination revealed a yellow placoid lesion at the limbus, extending toward the center of the cornea. The surface of the cornea and adjacent conjunctiva were smooth, and there were no signs of inflammation \[[Fig. 1a](#F1){ref-type="fig"}\]. The patient was advised surgical removal of the mass. When a small incision was made in the superior aspect of the lesion, and gentle pressure was applied, yellowish material extruded from it \[[Fig. 1b](#F1){ref-type="fig"}\]. The material was collected, placed on a slide, and sent for cytopathological examination. Intraoperatively, we noted that there was a cleavage within the corneal stroma filled with the yellowish material. The remainder of the material was aspirated and washed with normal saline \[[Fig. 1c](#F1){ref-type="fig"}\]. We further observed that the yellowish material extended to the intrascleral space adjacent to the cornea. Hence, we presumed the lesion was possibly an intrascleral lipoma with corneal extension \[[Fig. 1d](#F1){ref-type="fig"}\]. Cytopathological examination confirmed the presence of lipid material containing clear vacuolated fat cells with the nuclei pushed to the periphery. There was no evidence of inflammatory cell infiltration \[[Fig. 2](#F2){ref-type="fig"}\]. Immunohistochemistry confirmed S100 positivity, suggestive of mature adipocytes. Postoperatively, the patient recovered well, with a clear cornea at the site of the lesion. There was no recurrence at 6-week follow-up \[[Fig. 3](#F3){ref-type="fig"}\].

![(a) A smooth surfaced yellow lesion in the nasal part of the cornea in the left eye (b) Surgical incision given over the lesion (c) Showing yellowish lipid-like material extruding out (d) Demonstration of lamellar scleral extension of the lesion](IJO-66-455-g001){#F1}

![Multiple vacuolated cells seen in hematoxylin and eosin stain with nucleus pushed to periphery suggestive of mature adipocytes](IJO-66-455-g002){#F2}

![Postoperative picture of the eye at the end of 6 weeks showing no recurrence](IJO-66-455-g003){#F3}

Discussion {#sec1-3}
==========

Lipomas are well-circumscribed benign lesions filled with fat cells in lobules surrounded by connective tissue. A meta-analysis of the largest orbital tumor series demonstrated a very low incidence of lipoma.\[[@ref2]\] A review of 1264 consecutive lesions conducted by Shields *et al*. reported only two lipomas, which is indicative of the rarity of this benign tumor in the eye and orbit.\[[@ref3]\] The occurrence of lipomas and their variants in various parts of the orbit has been reported worldwide; however, lipomas are rarely observed in the cornea.\[[@ref4][@ref5][@ref6]\] Lipomas are always confused with the prolapse of the retro-orbital fat, which commonly occurs in the superotemporal aspect of the globe.\[[@ref7]\] The cornea is an avascular structure of the globe; thus, the occurrence of a lipoma is theoretically confounding; however, the extension of a lipoma from the limbal area into the cornea is possible. Congenital dermolipoma of the limbus is rarely observed in isolation or as part of a syndrome, but histopathology usually reveals a dermatological component in addition to lipocytes.\[[@ref8]\] In our case, cytopathological examination revealed only mature adipocytes, confirmed by S100 positivity on immunohistochemistry.\[[@ref9]\]

Conclusion {#sec1-4}
==========

The rare possibility of lipoma may be considered in a yellow corneal lesion with smooth surface.
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